Barclays Rises 32.3% YTD: Is it the Right Time to Buy the Stock?

11.06.25 17:18 Uhr

Werte in diesem Artikel
Aktien

3,81 EUR -0,03 EUR -0,78%

Indizes

8.884,9 PKT 20,6 PKT 0,23%

4.823,6 PKT 8,1 PKT 0,17%

2.236,0 PKT 32,7 PKT 1,48%

8.435,7 PKT 9,7 PKT 0,11%

Year to date, shares of Barclays PLC BCS have risen 32.3%. The stock has outperformed the S&P 500 index, the Zacks Finance sector, and the industry. Meanwhile, it has underperformed its close peer, Deutsche Bank DB, while outperforming HSBC Holdings PLC HSBC.Year-to-Date Price PerformanceImage Source: Zacks Investment ResearchHowever, lingering uncertainty around tariff policies continues to pose risks. Given this backdrop, let’s assess whether Barclays stock is a lucrative bet or not.Growth Drivers for BarclaysRestructuring Efforts to Boost Profitability: Barclays has been taking steps to divest unprofitable/less profitable operations and save expenses through business streamlining, while deploying capital into higher revenue-generating areas.In February 2025, Barclays sold its consumer finance business in Germany. Last year, the company transformed its operating divisions and divested its Italian mortgage portfolio and $1.1 billion in credit card receivables.Through these efforts, Barclays recorded gross savings of £1 billion in 2024 and £150 million in the first quarter of 2025. The company aims to achieve gross efficiency savings of £0.5 billion this year. By 2026, management expects total gross efficiency savings to be £2 billion and the cost-to-income ratio to be in the high 50s. Its first-quarter 2025 cost-to-income ratio was 57%.The company is investing these savings in high-growth businesses and markets. This April, Barclays entered into a collaboration with Brookfield Asset Management Ltd. to reshape its payment acceptance business with plans to inject roughly £400 million. In March, the bank had announced a capital injection of more than INR2,300 crore (£210 million) into its India operations, following an injection of almost INR3,000 crore (£300 million) in 2021. Last year, the company acquired Tesco’s retail banking business, which complements its existing business. In 2023, Barclays acquired Kensington Mortgage, which bolstered its mortgage business.The redeployment of capital into higher-growth businesses and markets through improving efficiency is a multifaceted approach to boosting profitability. Barclays remains committed to this approach, which is likely to help improve profitability over time.Encouraging Capital Distributions: As of March 31, 2025, Barclays' liquidity coverage ratio and net stable funding ratio were 175.3% and 136.2%, respectively, well above the regulatory requirements. This indicates a solid liquidity and funding profile. Thus, a solid balance sheet position supports its enhanced capital distributions.The company has been paying dividends regularly and plans to keep the total dividend payout stable at the 2023 level, with progressive dividend growth.Barclays plans to return at least £10 billion of capital to shareholders between 2024 and 2026 through dividends and share buybacks, with a continued preference for buybacks.The bank has increased dividends six times in the past five years with an annualized growth rate of 45.04%. It has a dividend payout ratio of 28%.Barclays Dividend YieldImage Source: Zacks Investment ResearchBullish Analyst Sentiments for BarclaysOver the past two months, the Zacks Consensus Estimate for 2025 earnings per share has been revised 6.2% and 3% upward to $2.23 and $2.73, respectively.Estimate Revision TrendImage Source: Zacks Investment ResearchThe Zacks Consensus Estimate for Barclays’ 2025 and 2026 earnings implies year-over-year growth of 21.2% and 22.6%, respectively. (Find the latest EPS estimates and surprises on Zacks Earnings Calendar.)Barclays Shares Are UndervaluedBCS stock is currently trading at a forward 12-month price/earnings (P/E) of 7.17X. This is below the industry’s 9.4X, reflecting an attractive valuation.Price-to-Earnings F12MImage Source: Zacks Investment ResearchOn the other hand, Deutsche Bank and HSBC have a forward P/E of 8.31X and 8.64X, respectively. This reflects that Barclays is trading at a discount compared to its peers.Delay in IB Rebound to Hurt Barclays?Entering 2025, a major rebound in mergers and acquisitions (M&As) was expected, with deal-making activities likely to grow in the mid-20s. This optimism stemmed from pent-up demand, stabilizing or declining interest rates, tightening credit spreads, and strong public market valuations. Also, the Trump administration was perceived as business-friendly, with an expected removal of stringent oversight that could mark the end of the prolonged regulatory scrutiny.None of these has transpired till now. Deal-making activities have been muted as ambiguity over the tariff and ensuing trade war has resulted in extreme market volatility. These developments have led to economic uncertainty. Against such a backdrop, companies are rethinking their M&A plans despite stabilizing rates and having significant investible capital.Barclays management expects investment banking risk-weighted assets (RWAs) to be 50% of the Group RWAs in 2026. Further, the delay in the M&A rebound will impact the IB business of other global banks, including HSBC and Deutsche Bank, impacting revenue growth to some extent.How to Play Barclays Stock NowBarclays' restructuring efforts to boost efficiency and redeployment of capital to higher revenue-generating businesses are likely to help the company’s financials. Further, a solid liquidity profile enables sustainable capital distributions. Bullish analyst sentiments and attractive valuations are other positives.However, the bank’s core operating performance remains a concern. Net interest income (NII) and net fee, commission, and other income have been witnessing a volatile trend over the last several quarters owing to a tough operating backdrop. Though NII and net fee, commission, and other income rose in 2024 and in the first quarter of 2025, in light of structural hedges and Tesco bank buyout, the uncertainty about the performance of the capital markets might weigh on the company’s top line, which makes us apprehensive about its growth prospects. Further, the likelihood of a significant IB rebound this year remains low amid concerns regarding tariff policies, making BCS stock a cautious bet.Current shareholders may benefit from holding for strong long-term returns, while potential investors should wait for greater macroeconomic clarity before taking a position.Barclays currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.Zacks' Research Chief Names "Stock Most Likely to Double"Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.This top pick is a little-known satellite-based communications firm. Space is projected to become a trillion dollar industry, and this company's customer base is growing fast. Analysts have forecasted a major revenue breakout in 2025. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Hims & Hers Health, which shot up +209%.Free: See Our Top Stock And 4 Runners UpWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Barclays PLC (BCS): Free Stock Analysis Report Deutsche Bank Aktiengesellschaft (DB): Free Stock Analysis Report HSBC Holdings plc (HSBC): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.

Ausgewählte Hebelprodukte auf Barclays

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Barclays

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Barclays plc

Wer­bung

Analysen zu Barclays plc

DatumRatingAnalyst
07.04.2025Barclays OverweightJP Morgan Chase & Co.
27.12.2024Barclays OutperformRBC Capital Markets
22.08.2024Barclays BuyJefferies & Company Inc.
24.06.2024Barclays BuyJefferies & Company Inc.
25.04.2024Barclays BuyUBS AG
DatumRatingAnalyst
07.04.2025Barclays OverweightJP Morgan Chase & Co.
27.12.2024Barclays OutperformRBC Capital Markets
22.08.2024Barclays BuyJefferies & Company Inc.
24.06.2024Barclays BuyJefferies & Company Inc.
25.04.2024Barclays BuyUBS AG
DatumRatingAnalyst
22.09.2023Barclays HoldDeutsche Bank AG
28.04.2023Barclays HoldDeutsche Bank AG
27.10.2022Barclays HoldDeutsche Bank AG
27.10.2022Barclays Sector PerformRBC Capital Markets
26.10.2022Barclays NeutralJP Morgan Chase & Co.
DatumRatingAnalyst
20.03.2018Barclays SellCitigroup Corp.
23.02.2018Barclays SellGoldman Sachs Group Inc.
21.02.2018Barclays SellGoldman Sachs Group Inc.
16.02.2018Barclays SellGoldman Sachs Group Inc.
17.01.2018Barclays SellGoldman Sachs Group Inc.

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Barclays plc nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen